• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • Mailing List
Home
  • ATTEND
    • Show Overview
    • Who Attends
    • Fierce 15 Awards
    • Stay Updated
  • COMMUNITIES
    • Drug Development
    • Clinical
    • BD&L
    • Trial Master File
    • PR & Communications
  • AGENDA
    • Full Agenda
    • Drug Development
    • Clinical
    • BD&L
    • Trial Master File
    • PR & Communications
  • PLAN YOUR VISIT
    • Encore Boston Harbor Hotel & Casino
  • SPEAKERS
    • Meet the Speakers
    • Call for Speakers
  • PARTNERS
    • 2025 Partners
    • Floor Plan
    • Become a Sponsor
  • REGISTER
Home
Hamburger Menu Hamburger Menu
  • ATTEND
    • Show Overview
    • Who Attends
    • Fierce 15 Awards
    • Stay Updated
  • COMMUNITIES
    • Drug Development
    • Clinical
    • BD&L
    • Trial Master File
    • PR & Communications
  • AGENDA
    • Full Agenda
    • Drug Development
    • Clinical
    • BD&L
    • Trial Master File
    • PR & Communications
  • PLAN YOUR VISIT
    • Encore Boston Harbor Hotel & Casino
  • SPEAKERS
    • Meet the Speakers
    • Call for Speakers
  • PARTNERS
    • 2025 Partners
    • Floor Plan
    • Become a Sponsor
  • REGISTER
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • Mailing List

Chris Arendt

Chief Science Officer, Head of Research

Takeda

Sessions:

Speaker Panel: How AI/ML is Accelerating Drug Development
See full schedule
Home
  • Connect
    • Advertise
    • Media Kit
    • Sponsorships
    • Contact Us
  • Join Us
    • Join Our Mailing List
    • Newsletters
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Clinical & Regulatory
    • Marketing & Communications
    • Medical Affairs
    • R&D and Drug Development
    • Strategy
    • Healthcare
    • Awards
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings